Treatment of Serratia marcescens UTI in a 13-Week Pregnant Woman with Penicillin Allergy
For a 13-week pregnant woman with Serratia marcescens UTI and penicillin allergy, aztreonam is the safest and most effective treatment option.
Assessment of Penicillin Allergy Status
First, determine the severity of the penicillin allergy:
- Low risk for anaphylaxis: No history of anaphylaxis, angioedema, respiratory distress, or urticaria following penicillin or cephalosporin administration
- High risk for anaphylaxis: History of anaphylaxis, angioedema, respiratory distress, or urticaria following penicillin or cephalosporin administration
Treatment Algorithm
First-line Treatment
- Aztreonam (1-2g IV every 8 hours or 500mg-1g IV every 6-8 hours) 1
- FDA-approved for UTIs caused by Serratia marcescens
- Safe in pregnancy
- No cross-reactivity with penicillin allergy
- Excellent gram-negative coverage
Alternative Options Based on Susceptibility Testing
If susceptibility testing is available, consider:
For patients at low risk for anaphylaxis:
For patients at high risk for anaphylaxis:
- Aminoglycosides (e.g., amikacin) - based on susceptibility testing 4
- Consider lower doses and monitoring levels due to pregnancy
Duration of Treatment
- Uncomplicated UTI: 7-10 days
- Complicated UTI: 10-14 days
Important Considerations
Pregnancy-Specific Concerns
- Avoid fluoroquinolones and tetracyclines due to potential fetal risks
- Monitor renal function and drug levels if aminoglycosides are used
- Consider hospitalization for IV therapy if symptoms are severe
Serratia marcescens Characteristics
- Often resistant to multiple antibiotics including ampicillin, first-generation cephalosporins, and nitrofurantoin 4
- Susceptibility to carbapenems and aminoglycosides is typically preserved 4
Follow-up
- Obtain urine culture 1-2 weeks after completing therapy to confirm clearance
- Monitor for recurrence throughout pregnancy
- Consider monthly urine cultures for the remainder of pregnancy
Pitfalls to Avoid
- Do not use nitrofurantoin for Serratia marcescens (intrinsic resistance)
- Do not use ampicillin or first-generation cephalosporins (high resistance rates)
- Do not assume all cephalosporins are contraindicated in penicillin allergy (only ~10% cross-reactivity)
- Do not delay treatment while waiting for susceptibility testing if the patient is symptomatic
Aztreonam represents the safest option for treating Serratia marcescens UTI in a pregnant woman with penicillin allergy, as it provides effective coverage against the organism without cross-reactivity with penicillin allergy.